NASDAQ : NRXP
NRx Pharmaceuticals, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 2.66 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 115.08M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
NRx Pharmaceuticals, Inc. (NRXP) reported revenue of 3.39M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 3.39M | 1.23M | ||||
| Cost of Revenue | 1.81M | 505.00K | ||||
| Gross Profit | 1.58M | 720.00K | ||||
| Selling, General & Admin | 15.93M | 13.06M | 13.50M | 14.22M | 27.31M | 74.94M |
| Research & Development | 5.41M | 3.78M | 6.20M | 13.37M | 17.03M | 20.26M |
| Other Operating Expenses | -771.00K | |||||
| Operating Expenses | 21.55M | 16.91M | 19.70M | 27.59M | 44.34M | 94.43M |
| Operating Income | -19.96M | -16.19M | -19.70M | -27.59M | -44.34M | -94.43M |
| Interest Expense | -1.14M | -671.00K | -230.00K | -120.00K | -18.00K | |
| Interest & Investment Income | 17.00K | 12.00K | 44.00K | 494.00K | 249.00K | |
| Other Non Operating Income (Expenses) | -5.02M | -7.76M | -3.78M | 20.00K | 255.00K | 1.69M |
| EBT Excluding Unusual Items | -26.10M | -24.61M | -23.67M | -27.19M | -43.83M | -92.76M |
| Gain (Loss) on Sale of Investments | -35.00K | -35.00K | ||||
| Other Unusual Items | 2.66M | -3.98M | -1.45M | -2.96M | 4.08M | -307.00K |
| Pretax Income | -23.48M | -28.62M | -25.13M | -30.15M | -39.75M | -93.06M |
| Net Income | -23.48M | -28.62M | -25.13M | -30.15M | -39.75M | -93.06M |
| Preferred Dividends & Other Adjustments | 9.00K | |||||
| Net Income to Common | -23.48M | -28.62M | -25.13M | -30.16M | -39.75M | -93.06M |
| Shares Outstanding (Basic) | 30.28M | 21.40M | 10.64M | 7.58M | 6.58M | 4.69M |
| Shares Outstanding (Diluted) | 30.28M | 21.40M | 10.64M | 7.58M | 6.58M | 4.69M |
| EPS (Basic) | -0.78 | -1.34 | -2.36 | -3.98 | -6.04 | -19.84 |
| EPS (Diluted) | -0.78 | -1.34 | -2.36 | -3.98 | -6.04 | -74.40 |
| Free Cash Flow | -20.67M | -14.11M | -10.64M | -21.66M | -39.77M | -37.71M |
| Free Cash Flow Per Share | -0.68 | -0.66 | -1.00 | -2.86 | -6.05 | -8.04 |
| Gross Margin | 46.64% | 58.78% | ||||
| Operating Margin | -588.21% | -1,321.47% | ||||
| Profit Margin | -691.81% | -2,336.49% | ||||
| Free Cash Flow Margin | -609.04% | -1,152.00% | ||||
| EBITDA | -19.76M | -16.12M | -19.70M | -27.58M | -44.33M | -94.43M |
| D&A For EBITDA | 202.00K | 70.00K | 5.00K | 5.00K | 4.00K | 2.00K |
| EBIT | -19.96M | -16.19M | -19.70M | -27.59M | -44.34M | -94.43M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 26.69M | 7.80M | 1.44M | 4.59M | 20.05M | 27.61M |
| Cash & Short-Term Investments | 26.69M | 7.80M | 1.44M | 4.59M | 20.05M | 27.61M |
| Accounts Receivable | 206.00K | 161.00K | ||||
| Other Receivables | 6.00K | 7.00K | ||||
| Receivables | 206.00K | 161.00K | 6.00K | 7.00K | ||
| Prepaid Expenses | 1.19M | 590.00K | 1.03M | 1.41M | 3.77M | 4.60M |
| Other Current Assets | 1.08M | 344.00K | 824.00K | 871.00K | 1.97M | 512.00K |
| Total Current Assets | 29.16M | 8.89M | 3.30M | 6.88M | 25.80M | 32.71M |
| Property, Plant & Equipment | 1.75M | 696.00K | 10.00K | |||
| Long-Term Investments | 402.00K | 397.00K | ||||
| Goodwill | 1.79M | 1.79M | ||||
| Other Intangible Assets | 832.00K | 925.00K | ||||
| Other Long-Term Assets | 224.00K | 253.00K | 339.00K | 431.00K | 21.00K | 15.00K |
| Total Assets | 34.16M | 12.96M | 3.65M | 7.32M | 25.82M | 32.73M |
| Accounts Payable | 3.15M | 4.27M | 4.13M | 4.63M | 2.08M | 3.69M |
| Accrued Expenses | 6.02M | 5.62M | 6.13M | 5.24M | 5.77M | 2.84M |
| Current Portion of Long-Term Debt | 1.25M | 9.16M | 7.70M | 518.00K | ||
| Current Portion of Leases | 378.00K | 316.00K | ||||
| Other Current Liabilities | 24.33M | 18.37M | 10.35M | 17.00K | 37.00K | 4.87M |
| Total Current Liabilities | 33.87M | 28.58M | 21.86M | 19.05M | 15.59M | 11.92M |
| Long-Term Debt | 5.01M | 2.82M | ||||
| Long-Term Leases | 456.00K | 315.00K | ||||
| Total Liabilities | 34.33M | 28.89M | 26.87M | 19.05M | 18.41M | 11.92M |
| Common Stock | 43.00K | 32.00K | 15.00K | 8.00K | 67.00K | 59.00K |
| Additional Paid-In Capital | 324.63M | 290.93M | 255.03M | 241.41M | 230.34M | 203.99M |
| Retained Earnings | -324.85M | -306.89M | -278.27M | -253.15M | -223.00M | -183.24M |
| Comprehensive Income & Other | -3.00K | |||||
| Total Common Equity | -170.00K | -15.94M | -23.22M | -11.74M | 7.41M | 20.81M |
| Shareholders' Equity | -170.00K | -15.94M | -23.22M | -11.73M | 7.41M | 20.81M |
| Total Liabilities & Equity | 34.16M | 12.96M | 3.65M | 7.32M | 25.82M | 32.73M |
| Total Debt | 834.00K | 631.00K | 6.26M | 9.16M | 10.53M | 518.00K |
| Net Cash (Debt) | 25.85M | 7.17M | -4.81M | -4.57M | 9.53M | 27.09M |
| Net Cash Per Share | 0.85 | 0.33 | -0.45 | -0.60 | 1.45 | 5.77 |
| Filing Date Shares Outstanding | 43.26M | 33.03M | 16.92M | 9.45M | 7.06M | 6.66M |
| Total Common Shares Outstanding | 43.12M | 31.70M | 14.59M | 8.27M | 6.54M | 5.88M |
| Working Capital | -4.72M | -19.69M | -18.56M | -12.16M | 10.21M | 20.79M |
| Book Value Per Share | -0.00 | -0.50 | -1.59 | -1.42 | 1.13 | 3.54 |
| Tangible Book Value | -2.79M | -18.66M | -23.22M | -11.74M | 7.41M | 20.81M |
| Tangible Book Value Per Share | -0.06 | -0.59 | -1.59 | -1.42 | 1.13 | 3.54 |
| Machinery | 919.00K | 93.00K | 29.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -23.48M | -28.62M | -25.13M | -30.15M | -39.75M | -93.06M |
| Depreciation & Amortization | 481.00K | 143.00K | 5.00K | 5.00K | 4.00K | 2.00K |
| Other Amortization | 350.00K | 896.00K | ||||
| Loss (Gain) on Equity Investments | 30.00K | 35.00K | ||||
| Stock-Based Compensation | 1.86M | 829.00K | 523.00K | 387.00K | 3.63M | 7.79M |
| Provision & Write-off of Bad Debts | 93.00K | 40.00K | ||||
| Other Operating Activities | 2.43M | 11.70M | 7.77M | 2.94M | -4.33M | 52.47M |
| Change in Accounts Receivable | -50.00K | 48.00K | 831.00K | |||
| Change in Accounts Payable | -510.00K | 113.00K | -5.22M | 2.65M | -1.61M | -19.00K |
| Change in Other Net Operating Assets | -629.00K | 1.25M | 10.51M | 2.51M | 2.31M | -5.71M |
| Operating Cash Flow | -19.77M | -14.11M | -10.64M | -21.66M | -39.76M | -37.70M |
| Capital Expenditures | -897.00K | -3.00K | -10.00K | -7.00K | ||
| Cash Acquisitions | -2.38M | -2.38M | ||||
| Investment in Securities | -432.00K | -432.00K | ||||
| Investing Cash Flow | -3.71M | -2.81M | -3.00K | -10.00K | -7.00K | |
| Short-Term Debt Issued | 227.00K | 1.04M | 943.00K | |||
| Long-Term Debt Issued | 5.00M | 6.03M | 10.02M | |||
| Total Debt Issued | 237.00K | 5.23M | 7.08M | 943.00K | 10.02M | |
| Short-Term Debt Repaid | -548.00K | -725.00K | -943.00K | -176.00K | ||
| Long-Term Debt Repaid | -7.85M | -3.09M | -518.00K | -1.10M | ||
| Total Debt Repaid | -204.00K | -548.00K | -8.57M | -4.04M | -518.00K | -1.28M |
| Net Debt Issued (Repaid) | 33.00K | 4.68M | -1.50M | -3.09M | 9.50M | -1.28M |
| Issuance of Common Stock | 26.93M | 9.47M | 5.91M | 8.12M | 22.71M | 53.68M |
| Other Financing Activities | 20.30M | 9.13M | 3.07M | 11.05M | ||
| Financing Cash Flow | 47.26M | 23.28M | 7.49M | 6.20M | 32.21M | 63.46M |
| Net Cash Flow | 23.78M | 6.35M | -3.15M | -15.46M | -7.55M | 25.75M |
| Free Cash Flow | -20.67M | -14.11M | -10.64M | -21.66M | -39.77M | -37.71M |
| Free Cash Flow Margin | -609.04% | -1,152.00% | ||||
| Free Cash Flow Per Share | -0.68 | -0.66 | -1.00 | -2.86 | -6.05 | -8.04 |
| Levered Free Cash Flow | -9.64M | -805.88K | 126.25K | -11.47M | -28.24M | -89.80M |
| Unlevered Free Cash Flow | -8.93M | -736.50K | -626.00K | -11.40M | -28.24M | -89.79M |
| Cash Interest Paid | 374.00K | 885.00K | ||||
| Change in Working Capital | -1.19M | 1.41M | 5.29M | 5.16M | 699.00K | -4.90M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 98.21M | 80.23M | 26.53M | 38.30M | 75.08M | 281.11M |
| Enterprise Value | 72.35M | 83.30M | 30.92M | 39.47M | 56.83M | 242.74M |
| Last Close Price | 2.27 | 2.71 | 2.20 | 4.60 | 11.10 | 47.80 |
| Forward PE | 39.16 | |||||
| PS Ratio | 28.94 | 65.49 | ||||
| PB Ratio | -5.03 | -1.14 | -3.26 | 10.13 | 13.51 | |
| P/TBV Ratio | 10.13 | 13.51 | ||||
| EV/Sales Ratio | 21.32 | 68.00 | ||||
| Debt / Equity Ratio | -4.91 | -0.04 | -0.27 | -0.78 | 1.42 | 0.03 |
| Net Debt / Equity Ratio | 152.07 | 0.45 | -0.21 | -0.39 | -1.29 | -1.30 |
| Net Debt / EBITDA Ratio | 1.31 | 0.45 | -0.24 | -0.17 | 0.21 | 0.29 |
| Net Debt / FCF Ratio | 1.25 | 0.51 | -0.45 | -0.21 | 0.24 | 0.72 |
| Asset Turnover | 0.17 | 0.15 | ||||
| Quick Ratio | 0.79 | 0.28 | 0.07 | 0.24 | 1.29 | 2.31 |
| Current Ratio | 0.86 | 0.31 | 0.15 | 0.36 | 1.66 | 2.74 |
| Return on Equity (ROE) | -281.79% | |||||
| Return on Assets (ROA) | -63.99% | -121.85% | -224.60% | -104.08% | -94.66% | -330.91% |
| Return on Capital Employed (ROCE) | -6,980.40% | 103.60% | 108.20% | 235.10% | -433.30% | -453.90% |
| Earnings Yield | -34.16% | -35.68% | -94.69% | -78.73% | -52.95% | -33.11% |
| FCF Yield | -21.05% | -17.59% | -40.09% | -56.56% | -52.96% | -13.41% |
| Buyback Yield / Dilution | -110.42% | -101.06% | -40.50% | -15.20% | -40.17% | -36.90% |